PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $137 | -11.6% | 13,235 | +22.4% | 0.00% | – |
Q2 2023 | $155 | +74.2% | 10,813 | -13.7% | 0.00% | – |
Q1 2023 | $89 | -11.0% | 12,526 | +41.1% | 0.00% | – |
Q4 2022 | $100 | -99.1% | 8,879 | +809.7% | 0.00% | – |
Q3 2022 | $11,000 | -72.5% | 976 | -79.5% | 0.00% | – |
Q2 2022 | $40,000 | -57.4% | 4,767 | -31.6% | 0.00% | – |
Q1 2022 | $94,000 | – | 6,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |